Annual Operating Expenses
$27.39 M
+$7.79 M+39.76%
30 June 2024
Summary:
Renovaro Biosciences annual total operating expenses is currently $27.39 million, with the most recent change of +$7.79 million (+39.76%) on 30 June 2024. During the last 3 years, it has risen by +$3.99 million (+17.04%). RENB annual operating expenses is now at all-time high.RENB Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$5.72 M
+$259.50 K+4.75%
30 September 2024
Summary:
Renovaro Biosciences quarterly total operating expenses is currently $5.72 million, with the most recent change of +$259.50 thousand (+4.75%) on 30 September 2024. Over the past year, it has dropped by -$3.16 million (-35.57%). RENB quarterly operating expenses is now -59.65% below its all-time high of $14.18 million, reached on 01 June 2021.RENB Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RENB Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +39.8% | -35.6% |
| 3 y3 years | +17.0% | -9.6% |
| 5 y5 years | +149.2% | +103.1% |
RENB Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +39.8% | -35.6% | +44.0% |
| 5 y | 5 years | at high | +149.2% | -59.6% | +103.1% |
| alltime | all time | at high | >+9999.0% | -59.6% |
Renovaro Biosciences Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.72 M(+4.7%) |
| June 2024 | $27.39 M(+39.8%) | $5.46 M(-37.7%) |
| Mar 2024 | - | $8.77 M(+105.4%) |
| Dec 2023 | - | $4.27 M(-51.9%) |
| Sept 2023 | - | $8.88 M(+123.5%) |
| June 2023 | $19.60 M(-14.1%) | - |
| June 2023 | - | $3.98 M(-2.2%) |
| Mar 2023 | - | $4.06 M(-7.0%) |
| Dec 2022 | - | $4.37 M(-39.3%) |
| Sept 2022 | - | $7.19 M(+45.1%) |
| June 2022 | $22.83 M(-2.5%) | $4.96 M(+22.8%) |
| Mar 2022 | - | $4.03 M(-36.3%) |
| Dec 2021 | - | $6.33 M(-15.6%) |
| Sept 2021 | - | $7.50 M(-47.1%) |
| June 2021 | $23.40 M(+96.3%) | $14.18 M(+364.5%) |
| Mar 2021 | - | $3.05 M(-7.6%) |
| Dec 2020 | - | $3.31 M(+15.6%) |
| Sept 2020 | - | $2.86 M(+0.9%) |
| June 2020 | $11.92 M(+8.5%) | $2.83 M(-26.0%) |
| Mar 2020 | - | $3.83 M(+35.9%) |
| Dec 2019 | - | $2.82 M(+15.4%) |
| Sept 2019 | - | $2.44 M(+15.8%) |
| June 2019 | $10.99 M(+106.2%) | $2.11 M(-21.4%) |
| Mar 2019 | - | $2.69 M(-38.7%) |
| Dec 2018 | - | $4.38 M(+141.7%) |
| Sept 2018 | - | $1.81 M(+888.5%) |
| June 2018 | $5.33 M | $183.40 K(-94.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $3.24 M(+152.8%) |
| Dec 2017 | - | $1.28 M(+104.7%) |
| Sept 2017 | - | $625.80 K(-3.5%) |
| June 2017 | $2.40 M(+11.2%) | $648.30 K(+84.7%) |
| Mar 2017 | - | $351.00 K(-36.0%) |
| Dec 2016 | - | $548.80 K(-35.6%) |
| Sept 2016 | - | $852.30 K(+27.0%) |
| June 2016 | $2.16 M(-19.1%) | $671.20 K(+30.7%) |
| Mar 2016 | - | $513.60 K(-18.8%) |
| Dec 2015 | - | $632.20 K(+85.2%) |
| Sept 2015 | - | $341.40 K(-58.4%) |
| June 2015 | $2.67 M(+25.1%) | - |
| Mar 2015 | - | $820.90 K(-5.1%) |
| Dec 2014 | $2.13 M(+5650.9%) | $865.10 K(+133.7%) |
| Sept 2014 | - | $370.20 K(-26.5%) |
| June 2014 | - | $503.80 K(+27.7%) |
| Mar 2014 | - | $394.40 K(+4769.1%) |
| Dec 2013 | - | $8100.00(-49.4%) |
| Sept 2013 | - | $16.00 K(+540.0%) |
| June 2013 | - | $2500.00(-73.4%) |
| Mar 2013 | $37.10 K(+24.1%) | $9400.00(-2.1%) |
| Dec 2012 | - | $9600.00(+37.1%) |
| Sept 2012 | - | $7000.00(-36.4%) |
| June 2012 | - | $11.00 K(+150.0%) |
| Mar 2012 | $29.90 K(-12.8%) | $4400.00(-61.4%) |
| Dec 2011 | $34.30 K | $11.40 K(-19.7%) |
| Sept 2011 | - | $14.20 K(>+9900.0%) |
| June 2011 | - | $0.00 |
FAQ
- What is Renovaro Biosciences annual total operating expenses?
- What is the all time high annual operating expenses for Renovaro Biosciences?
- What is Renovaro Biosciences annual operating expenses year-on-year change?
- What is Renovaro Biosciences quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly operating expenses year-on-year change?
What is Renovaro Biosciences annual total operating expenses?
The current annual operating expenses of RENB is $27.39 M
What is the all time high annual operating expenses for Renovaro Biosciences?
Renovaro Biosciences all-time high annual total operating expenses is $27.39 M
What is Renovaro Biosciences annual operating expenses year-on-year change?
Over the past year, RENB annual total operating expenses has changed by +$7.79 M (+39.76%)
What is Renovaro Biosciences quarterly total operating expenses?
The current quarterly operating expenses of RENB is $5.72 M
What is the all time high quarterly operating expenses for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly total operating expenses is $14.18 M
What is Renovaro Biosciences quarterly operating expenses year-on-year change?
Over the past year, RENB quarterly total operating expenses has changed by -$3.16 M (-35.57%)